PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, providing promising advancements throughout various healthcare and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, much more reputable choice for therapeutic use,